T1	Participants 37 117	acute coronary syndromes in Canada: a long-term analysis based on the CURE trial
T2	Participants 394 469	The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial
T3	Participants 575 787	reducing cardiovascular events in patients with acute coronary syndromes and, in addition, patients undergoing percutaneous coronary intervention in the Percutaneous Coronary Intervention in CURE (PCI-CURE) trial
T4	Participants 854 881	Canadian health care system
T5	Participants 1646 1659	CURE patients
T6	Participants 1674 1691	PCI-CURE patients
